These nanovesicles were constructed from lipid-based liposomes and functionalized with a matrix metalloproteinase-2 (MMP-2)-sensitive peptide, internalizing RGD (iRGD), and PPa, facilitating deep tumor penetration and precise drug release. Here, MMP2 is linked to neoplasm.